Recording is available only for registered users.
Stockholm-based consulting company Synergus, European leader in market access for medical devices and diagnostics is growing and looking for the experienced researchers and consultants to join our team. Our main areas of expertise are market access, health economics, evidence synthesis and DRG systems.
European collaboration of health technology assessment bodies EUnetHTA is planning to perform rapid assessment of mitral valves. This may have substantial market access implications for many industry players in the field.
The German DRG institute have now published the new list with NUBs valid for 2015. Based on our analysis we identified 5 new products that have received category 1 for the first time. This is the category that enables the hospital to negotiate for innovation funding.
In total 23 out of 36 published HTA reports considered health economic data.The most common method of analysis was cost-effectiveness and cost-utility analysis. Majority of the studies (65%) conducted systematic review or de novo health economic analysis.
Our analytical service, HTA Update, detected 38 reports, related to 17 technologies from seven European countries in November 2014. Among 12 reports, which included recommendations, five (42%) had positive conclusions, two reports (17%) had conclusions of positive with restrictions, four reports (33%) were negative, one report (8%) was negative with technology recommended for research only (see figure below).